UVic Torch -- Fall 2004
Autumn 2004,
Volume 25, Number 2

Current Contents
back issues
Torch Editor
Torch Advertising
Address changes
Keep in Touch
About the torch
Order a Copy
Alumni Home
UVic Home
UVic
 
Contents   
Uvic Torch Online

 
Cancer Fighter - Photography by JO-ANN RICHARDS Cancer Fighter
Making fitness fun: Ryan Rhodes aboard one of the Cateye interactive bikes that combine exercise and video games.
Photography by JO-ANN RICHARDS


PROTOX THERAPEUTICS, WITH UVIC-BASED RESEARCH THAT HOLDS PROMISE for prostate cancer patients, has become the first UVic spin-off company to be listed on the TSX Venture Exchange.

UVic biochemist Tom Buckley has engineered a protein—Aerolysin—that punctures cancer cells. “We believe we can also tailor Aerolysin so that it can selectively destroy a variety of other types of cancer cells,” says Buckley, the new company’s chief scientific officer. Ongoing research is being conducted jointly with Johns Hopkins University.

The university’s technology transfer arm, the Innovation and Development Corporation, encouraged Buckley to go commercial. This summer the company began trading after the close of a $4.5-million public offering. In return for licensing the technology to Protox, UVic receives a stake in the company, royalties on product sales, plus other payments if certain milestones are reached.

Back to Ringside contents






© 2006 UVic Communications | Last updated: Mon, 6/22/09

Site Design by Rayola Graphic Design